BERLIN (Reuters) – Germany’s health minister will hold a meeting with his regional counterparts at 1800 CET (1600 GMT) on Tuesday to discuss the use of AstraZeneca’s COVID-19 vaccine, a health ministry spokesman said.
The meeting follows further reports by Germany’s vaccine regulator, the Paul Ehrlich Institute, of cases of blood clots known as cerebral sinus vein thrombosis (CSVT).
(Reporting by Caroline Copley; Editing by Madeline Chambers)
